US3257072A - Whole blood storage structure - Google Patents
Whole blood storage structure Download PDFInfo
- Publication number
- US3257072A US3257072A US249942A US24994263A US3257072A US 3257072 A US3257072 A US 3257072A US 249942 A US249942 A US 249942A US 24994263 A US24994263 A US 24994263A US 3257072 A US3257072 A US 3257072A
- Authority
- US
- United States
- Prior art keywords
- bag
- blood
- passage
- container
- whole blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/4673—Plural tanks or compartments with parallel flow
Definitions
- the plasma and the glucose-red cells mixture are thawed in a 37 C. water bath. After thawing, the major portion of the glucose is separated from the red cells by spinning in a centrifuge for three I minutes and then decanting. The original whole blood is then reconstituted by adding its thawed plasma and is ready for use in the human body.
- Another object of my invention is to provide a simple, durable and sterile container for storage and processing of whole bloodwhich is transparent or translucent and permits visual inspection of its contents at all times, and which is of such low cost as to be treated as a disposable item.
- a further object of the invention is to provide a multiple compartment container for whole blood storage and processing which is sterile and permits transfer of whole blood components and compatible solution as required for cryogenic storage and for later reconstituting, and which is formed of clear material permitting visual inspection of its contents at all times to and including introduction of the reconstituted blood into a patent.
- Still another object of the invention is to provide a system of using a multiple compartment sterile container in the cryogenic storage and subsequent reconstituting of whole blood which prevents any accidental mixing of separated plasma and red cells from different blood in the reconstituting procedure.
- FIG. 1 is a front elevation of a container being used in the processing and storage of whole blood withpassage-sealing members shown in dash lines;
- FIG. 2. is a section taken approximately on the line 2-2, FIG. 1, with clamping members shown in operating relation to other structure; and 7 FIG. 3 is a developed section taken a roximately along the line 33, FIG. 1, and showing the position of contents at a different stage of the processing than depicted in FIG. 2.
- the container 5 is formed as a circumferentially closed bag-like member of a clear ma terial, such as Teflon FEP fluorinated ethylene propylene, which will permit heat sealing and is clear for visual inspection, possesses the desired mechanical strength, clinically acceptable, and is flexible at liquid nitrogen temperature.
- a clear ma terial such as Teflon FEP fluorinated ethylene propylene
- a passage 10 is provided in partition 6 to permit exchange of stored material between compartments 7 and 8 and a similar passage 11 permits interchange of stored material between compartments 7 and 9.
- Each of the passages 10 and 11 may be selectively closed and secured against interchange of material :by a pinch-type device indicated by the dash lines 12.
- a headed passage 13 into compartment 7 permits introduction into and withdrawal of material from container 5 and a valve 14 which may be a clamping device is accessible from the outside of the container and effectively seals the entrance passage 13 except during introduction and withdrawal of material.
- a measured quantity of isotonic saline glucose solution is introduced through opening 13 with passage 11 open and the bag disposed with the opening 13 at its top.
- the charge to chamber 7 is directed through passage 11 into compartment 9 and when the complete charge is disposed therein, the clamp 12 is applied to close passage 11 and prevent interchange of material between compartments 7 and 9.
- a measured quantity of Whole blood is next introduced through passage 13 and when the entire charge is confined, the clamping member 14 is secured to complete the hermetic circumferential seal of container 5.
- Container 5 is next disposed in the position shown in FIG. 1 and is centrifuged for 3 minutes. After removal from The interior of the bag is partitioned-as the centrifuging operation, the red cells are collected in the bottom in a distinct layer separated from the plasma which stands above such cells.
- a clamping member 15 is then applied to the exterior of bag 5 along the lines of such separation and exerts suflicient force to completely separate blood cells from the plasma.
- the clamping member securing passage is then removed and the plasma is directed to flow through passage It) and fill compartment 8.
- the clamping member is again actuated to seal passage 10, after which clamping member is removed and the clamping member 12 securing passage 11 also is removed to permit outflow of the solution from compartment 9 into compartment 7 where it mixes with the red cells confined therein.
- the container 5 is then frozen in liquid nitrogen or cold nitrogen gas, and the portion of the bag containing the red cells will be restrained into a physical shape to have a thickness of 2 /2 centimeters more or less for proper freezing.
- the stored plasma in compartment 8 also is frozen to liquid nitrogen temperature and the plasma and red cells glucose solution may be stored at such temperatures for long periods without deterioration.
- the entire unit will be thawed in a warm water bath accompanied by agitation until the contents resume the liquid form.
- the unit is centrifuged again for 3 minutes to separate the glucose layer from the red cells.
- Clamping member 15 is affixed along the line of separation and passage 11 is opened to permit outflow of the solution into compartment 9.
- clamp 12 is applied to close passage 11 and the other clamp 12 is removed to open passage 10, permitting the plasma to descend into the compartment 7 and reconstitute the wholev blood.
- the blood is ready for use and the container 5 may be transported to the site of use and hung in the usual manner for withdrawal of the blood in treating a patient. Because of its relatively low cost, container 5 may be treated as a disposable item and disposed of when the whole blood charge is withdrawn.
- the container 5 as described above affords several advantages.
- the blood is collected and processed in one hermetically sealed unit and the red cells of the blood are never separated from its own plasma except within the confines of the container, thus avoiding any possible mixing of cells from one source with plasma from another source.
- the provision of a clear container permits visual observation of contents at all stages of the processing and during the final withdrawal of the reconstituted blood from the container, as during a transfusion.
- Teflon material in forming the bag meets all required criteria including the maintenance of sterile conditions, hermetical sealing after blood is placed in the container and adequate heat transfer during the freezing and thawing procedures. It possesses the requisitemechanical strength to withstand the centrifuging procedure and is compatible with blood and liquid nitrogen. Teflon is resistant to heat and can be sterilized. Two forms of Teflon are available commercially and suited for use in the practice of my invention. Teflon TFE is polytetrafluoroethylene, also sold as Halon TFE. The other sold under the name Teflon FEP is fluorinated ethylene propylene, a copolymer of TFE and hexafluoropropylene.
- partitioning arrangement providing a three compartment bag
- partitioning arrangement may be modified to provide any plurality of compartments required in such procedures and to maintain the contents of such compartments under sterile hermetically sealed condition as required.
- a container for the treatment and storage of whole blood comprising a flexible bag of translucent composition sterilized after fabrication and. having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for selective introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one liquid-sealing partition dividing the interior of the "bag into a plurality of treatment compartments, a passage in said partition for selective exchange of stored material between compartments, and means exteriorly of the bag for closing said passage by forcing opposite sides of the bag into sealing engagement in said passage, and said bag being characterized by:
- a container for the treatment and storage of whole blood comprising a flexible bag of a translucent composition selected from the group consisting of polytetrafluoroethylene and fiuorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for selective introduction and withdrawal of fluent material including a measured quantity of blood .at the beginning and end of a storage period, at least one horizontal partition dividing the interior of the bag into at least one upper and one lower treatment compartment, a passage in said compartment for selective exchange of stored material between adjoining upper and lower compartments, and means exteriorly of the bag for closing said passage by forcing opposite sides of the bag into sealing engagement in said passage, and said bag being characterized by:
- a container for the treatment and storage of whole blood comprising a flexible bag of a translucent compositlon selected from the group consisting of polytetrafluoroethylene and fluorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for SBIGCUVC introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one vertical partition dividing the interior of the bag into adjoining treatment compartments, a passage in one wall of each compartment for selective exchange of stored material between said compartments and an adjoining interior portion of the bag, and means exteriorly of the bag for closing said pas- (e) being flexible at all temperatures in a range from ambient to the temperature of liquid nitrogen.
- a container for the treatment and storage of whole blood comprising a flexible bag of a translucent composition selected from the group consisting of polytetrafluoroethylene and fluorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for selective introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one horizontal partition between opposed sides of the bag, a vertical partition extending from the horizontal partition to an outer edge of the bag, said partitions dividing the interior of the bag into an elongated material receiving compartment and two smaller exchange compartments, a passage at each end of the horizontal partition for selective exchange of stored material between the receiving compartment and an adjoining exchange compartment, and means exteriorly of the bag for closing said passage by forcing opposite sides of the bag into sealing engagement in said passage, and said bag being characterized by:
- a container for the treatment and storage of whole blood comprising a flexible bag of a translucent composition selected from the group consisting of polytetrafluoroethylene and fluorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means on the outside of the bag for selective introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one horizontal partition between opposed sides of the bag, a vertical partition extending from the horizontal partition to an outer edge of the bag, said partitions dividing the interior of the bag into an elongated material receiving compartment and two smaller exchange compartments, a passage at each end of the horizontal partition for selective exchange of stored material between the receiving compartment and an adjoining exchange compartment, means exteriorly of the bag for closing said passages by forcing opposite sides of the bag into sealing engagement in each said passage, pinch-type clamping means disposed on the exterior of the receiving compartment throughout its lengthwise extent for selective segregation of its contents according to
Description
June 21, 1966 M. M. REYNOLDS 3,
WHOLE BLOOD STORAGE STRUCTURE Filed Jan. 7, 1963 5 2 I I I K5 ii iyz l 15 ,I'ZZIIZZZIIIIIZI:2:12:12:
m w J Ti J P I g 03 INVENTOR.
Marfin M. Reynolds ATTORNEYS United States Patent 3,257,072 I WHOLE BLOOD STORAGE STRUCTURE Martin M. Reynolds, Denver, Colo., assignor to Cryogenie Engineering Company, Denver, Colo., a corporation of Colorado Filed Jan. 7, 1963, Ser. No. 249,942 Claims. (Cl. 23326) This invention relates to a method and means for storage of whole blood and has particular application to a novel type of multiple compartment clear container used in blood storage.
Until quite recently the accepted practice for storage and use of whole blood in this country has been to collect whole blood and store it at temperatures of about 38 F. It has been found that the blood cells break down at the rate' of about 1 percent per day and by the time 20 percent of the blood cells are hemolyzed, use of the stored blood in the human body may be dangerous. Consequently, a three week limit has been placed on the retention of whole blood under these conditions.
There has been a recent development of a clinically acceptable system for whole blood storage which permits the blood to be stored for relatively long periods without breakdown of the cells and which may be reconstituted at any time for safe use in the hurrnan body. This system involves introducing the whole blood into a container and centrifuging it for about 3 minutes. This serves to separate the red cells from-plasma and they are then moved to separate stonage areas. An isotonic saline citrated glucose solution is next added to the red cells to result in a 15 percent glucose solution. The separated plasma and the glucose-red cells mixture are then frozen separately and stored at liquid nitrogen temperature.
When it is desired to take the frozen blood for use in the human body, the plasma and the glucose-red cells mixture are thawed in a 37 C. water bath. After thawing, the major portion of the glucose is separated from the red cells by spinning in a centrifuge for three I minutes and then decanting. The original whole blood is then reconstituted by adding its thawed plasma and is ready for use in the human body.
One of the chief difficulties in the new storage system is the care that must be exercised to prevent contamination of the red cells or the plasma while separated and to insure the same red cell-plasma mixture being brought together in the reconstituting procedure.
Accordingly, it is an object of this invention to provide a storage container for whole blood which permits minimum handling to maintain sterility and keep out pyrogens, which is capable of being sterilized, which provides proper heat transfer during freezing and thawing operations, which has adequate mechanical strength to withstand the centrifuging operations, which is compatible with blood and liquid nitrogen and which confines the blood from the time of initial introduction until Withdrawal after reconstituting for use in the human body while permitting the specified separations within its hermetically sealed interior.
Another object of my invention is to provide a simple, durable and sterile container for storage and processing of whole bloodwhich is transparent or translucent and permits visual inspection of its contents at all times, and which is of such low cost as to be treated as a disposable item.
3,257,072 Patented June 21, 1966 A further object of the invention is to provide a multiple compartment container for whole blood storage and processing which is sterile and permits transfer of whole blood components and compatible solution as required for cryogenic storage and for later reconstituting, and which is formed of clear material permitting visual inspection of its contents at all times to and including introduction of the reconstituted blood into a patent.
Still another object of the invention is to provide a system of using a multiple compartment sterile container in the cryogenic storage and subsequent reconstituting of whole blood which prevents any accidental mixing of separated plasma and red cells from different blood in the reconstituting procedure.
Other objects reside in novel details of construction and novel combinations and arrangements of parts, all of which will be set forth in detail in the course of the following description.
The practice of my invention will be described with reference to the drawings illustrating one form of container embodying features of the invention. In the drawings, in the several views of which like parts bear similar reference numerals,
FIG. 1 is a front elevation of a container being used in the processing and storage of whole blood withpassage-sealing members shown in dash lines;
FIG. 2. is a section taken approximately on the line 2-2, FIG. 1, with clamping members shown in operating relation to other structure; and 7 FIG. 3 is a developed section taken a roximately along the line 33, FIG. 1, and showing the position of contents at a different stage of the processing than depicted in FIG. 2.
As shown in FIG. 1, the container 5 is formed as a circumferentially closed bag-like member of a clear ma terial, such as Teflon FEP fluorinated ethylene propylene, which will permit heat sealing and is clear for visual inspection, possesses the desired mechanical strength, clinically acceptable, and is flexible at liquid nitrogen temperature. shown at 6 and 6' by heat sealing, forming a larger blood storage chamber 7 and smaller storage containers 8 and 9, the functioning of which'will be described subsequently.
A passage 10 is provided in partition 6 to permit exchange of stored material between compartments 7 and 8 and a similar passage 11 permits interchange of stored material between compartments 7 and 9. Each of the passages 10 and 11 may be selectively closed and secured against interchange of material :by a pinch-type device indicated by the dash lines 12. A headed passage 13 into compartment 7 permits introduction into and withdrawal of material from container 5 and a valve 14 which may be a clamping device is accessible from the outside of the container and effectively seals the entrance passage 13 except during introduction and withdrawal of material.
At the beginning of a given operation, a measured quantity of isotonic saline glucose solution is introduced through opening 13 with passage 11 open and the bag disposed with the opening 13 at its top. The charge to chamber 7 is directed through passage 11 into compartment 9 and when the complete charge is disposed therein, the clamp 12 is applied to close passage 11 and prevent interchange of material between compartments 7 and 9.
A measured quantity of Whole blood is next introduced through passage 13 and when the entire charge is confined, the clamping member 14 is secured to complete the hermetic circumferential seal of container 5. Container 5 is next disposed in the position shown in FIG. 1 and is centrifuged for 3 minutes. After removal from The interior of the bag is partitioned-as the centrifuging operation, the red cells are collected in the bottom in a distinct layer separated from the plasma which stands above such cells. A clamping member 15 is then applied to the exterior of bag 5 along the lines of such separation and exerts suflicient force to completely separate blood cells from the plasma. The clamping member securing passage is then removed and the plasma is directed to flow through passage It) and fill compartment 8. When all of the plasma has been removed in this manner, the clamping member is again actuated to seal passage 10, after which clamping member is removed and the clamping member 12 securing passage 11 also is removed to permit outflow of the solution from compartment 9 into compartment 7 where it mixes with the red cells confined therein. The container 5 is then frozen in liquid nitrogen or cold nitrogen gas, and the portion of the bag containing the red cells will be restrained into a physical shape to have a thickness of 2 /2 centimeters more or less for proper freezing. In this same action, the stored plasma in compartment 8 also is frozen to liquid nitrogen temperature and the plasma and red cells glucose solution may be stored at such temperatures for long periods without deterioration.
After such a storage period when it is desired to use the stored contents, the entire unit will be thawed in a warm water bath accompanied by agitation until the contents resume the liquid form. At this time, the unit is centrifuged again for 3 minutes to separate the glucose layer from the red cells. Clamping member 15 is affixed along the line of separation and passage 11 is opened to permit outflow of the solution into compartment 9. When the entire solution charge is confined therein, clamp 12 is applied to close passage 11 and the other clamp 12 is removed to open passage 10, permitting the plasma to descend into the compartment 7 and reconstitute the wholev blood. At this stage, the blood is ready for use and the container 5 may be transported to the site of use and hung in the usual manner for withdrawal of the blood in treating a patient. Because of its relatively low cost, container 5 may be treated as a disposable item and disposed of when the whole blood charge is withdrawn.
Use of the container 5 as described above affords several advantages. The blood is collected and processed in one hermetically sealed unit and the red cells of the blood are never separated from its own plasma except within the confines of the container, thus avoiding any possible mixing of cells from one source with plasma from another source. The provision of a clear container permits visual observation of contents at all stages of the processing and during the final withdrawal of the reconstituted blood from the container, as during a transfusion.
The utilization of the Teflon material in forming the bag meets all required criteria including the maintenance of sterile conditions, hermetical sealing after blood is placed in the container and adequate heat transfer during the freezing and thawing procedures. It possesses the requisitemechanical strength to withstand the centrifuging procedure and is compatible with blood and liquid nitrogen. Teflon is resistant to heat and can be sterilized. Two forms of Teflon are available commercially and suited for use in the practice of my invention. Teflon TFE is polytetrafluoroethylene, also sold as Halon TFE. The other sold under the name Teflon FEP is fluorinated ethylene propylene, a copolymer of TFE and hexafluoropropylene.
By utilizing such a container in conjunction with the newly developed blood storage system, it is possible to safely store whole blood for long indefinite periods and to reconstitute it with original qualities and characteristics when it is to be used. The mixing of the red cells and glucose solution has been adequately tested and is an accepted method for preparing red cells for long period storage at liquid nitrogen temperatures.
While I have shown a partitioning arrangement provid ing a three compartment bag, it will be understood that the partitioning arrangement may be modified to provide any plurality of compartments required in such procedures and to maintain the contents of such compartments under sterile hermetically sealed condition as required. I have also indicated a preferred material for use in forming the container of the present invention, but it will be understood that any material possessing equivalent properties and characteristics may be used for this purpose.
I claim:
1. A container for the treatment and storage of whole blood, comprising a flexible bag of translucent composition sterilized after fabrication and. having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for selective introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one liquid-sealing partition dividing the interior of the "bag into a plurality of treatment compartments, a passage in said partition for selective exchange of stored material between compartments, and means exteriorly of the bag for closing said passage by forcing opposite sides of the bag into sealing engagement in said passage, and said bag being characterized by:
(a) its ability to withstand centrifugal forces of centrifuging,
(b) maintaining sterility of its contents,
(0) providing proper heat transfer in freezing and thawing operations,
(d) being compatible with blood and liquid nitrogen,
and
(e) being flexible at all temperatures in a range from ambient to the temperature of liquid nitrogen.
2. A container for the treatment and storage of whole blood, comprising a flexible bag of a translucent composition selected from the group consisting of polytetrafluoroethylene and fiuorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for selective introduction and withdrawal of fluent material including a measured quantity of blood .at the beginning and end of a storage period, at least one horizontal partition dividing the interior of the bag into at least one upper and one lower treatment compartment, a passage in said compartment for selective exchange of stored material between adjoining upper and lower compartments, and means exteriorly of the bag for closing said passage by forcing opposite sides of the bag into sealing engagement in said passage, and said bag being characterized by:
(a) its ability to Withstand centrifugal forces of centrifuging,
(b) maintaining sterility of its contents,
(0) providing proper heat transfer in freezing and thawing operations,
(d) going compatible with blood and liquid nitrogen,
(e) being flexible at all temperatures in a range from ambient to the temperature of liquid nitrogen.
3. A container for the treatment and storage of whole blood, comprising a flexible bag of a translucent compositlon selected from the group consisting of polytetrafluoroethylene and fluorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for SBIGCUVC introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one vertical partition dividing the interior of the bag into adjoining treatment compartments, a passage in one wall of each compartment for selective exchange of stored material between said compartments and an adjoining interior portion of the bag, and means exteriorly of the bag for closing said pas- (e) being flexible at all temperatures in a range from ambient to the temperature of liquid nitrogen.
4. A container for the treatment and storage of whole blood, comprising a flexible bag of a translucent composition selected from the group consisting of polytetrafluoroethylene and fluorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means for selective introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one horizontal partition between opposed sides of the bag, a vertical partition extending from the horizontal partition to an outer edge of the bag, said partitions dividing the interior of the bag into an elongated material receiving compartment and two smaller exchange compartments, a passage at each end of the horizontal partition for selective exchange of stored material between the receiving compartment and an adjoining exchange compartment, and means exteriorly of the bag for closing said passage by forcing opposite sides of the bag into sealing engagement in said passage, and said bag being characterized by:
(a) its ability to withstand centrifugal forces of centrifuging,
(b) maintaining sterility of its contents,
(c) providing proper heat transfer in freezing and thawing operations,
(d) being compatible with blood and liquid nitrogen,
and
(e) being flexible at all temperatures in a range from ambient to the temperature of liquid nitrogen.
5. A container for the treatment and storage of whole blood, comprising a flexible bag of a translucent composition selected from the group consisting of polytetrafluoroethylene and fluorinated ethylene propylene, said composition being sterilized after fabrication and having a circumferential enclosure providing a hermetic seal for the contents of the container, valve-controlled means on the outside of the bag for selective introduction and withdrawal of fluent material including a measured quantity of blood at the beginning and end of a storage period, at least one horizontal partition between opposed sides of the bag, a vertical partition extending from the horizontal partition to an outer edge of the bag, said partitions dividing the interior of the bag into an elongated material receiving compartment and two smaller exchange compartments, a passage at each end of the horizontal partition for selective exchange of stored material between the receiving compartment and an adjoining exchange compartment, means exteriorly of the bag for closing said passages by forcing opposite sides of the bag into sealing engagement in each said passage, pinch-type clamping means disposed on the exterior of the receiving compartment throughout its lengthwise extent for selective segregation of its contents according to composition, and said bag being characterized by:
(a) its ability to withstand centrifugal forces of centrifuging, (b) maintaining sterility of its contents, (c) providing proper heat transfer in freezing and thawing operations, ((1) being compatible with blood and liquid nitrogen,
and (e) being flexible at all temperatures in range from ambient to the temperature of liquid nitrogen.
References Cited by the Examiner UNITED STATES PATENTS 2,437,518 3/ 1948 Groenwall et al. 167-78 2,695,614 11/1954 Lockhart 128-272 2,753,990 7/1956 Chalfin et al 206-47 2,808,829 10/1957 Butler 128-272 2,833,691 5/1958 Klaas et al. 167-78 2,838,046 6/1958 Butler 128-272 2,893,547 7/ 1959 Earl et al 206-47 3,064,647 11/1962 Earl.
3,064,802 11/1962 Jess et a1. 206-47 3,082,867 3/1963 Gelpey 206-47 M. CARY NELSON, Primary Examiner.
EARL J. DRUM'MOND, Examiner.
J. CASKIE, H. KLI'NK'SIEK, Assistant Examiners.
Claims (1)
1. A CONTAINER FOR THE TREATMENT AND STORAGE OF WHOLE BLOOD, COMPRISING A FLEXIBLE BAG OF TRANSLUCENT COMPOSITION STERILIZED AFTER FABRICATION AND HAVING A CIRCUMFERENTIALL ENCLOSURE PROVIDING A HERMETIC SEAL FOR THE CONTENTS OF THE CONTAINER, VALVE-CONTROLLED MEANS FOR SELECTIVE INTRODUCTION AND WITHDRAWAL OF FLUENT MATERIAL INCLUDING A MEASURED QUANTITY OF BLOOD AT THE BEGINNING AND END OF A STORAGE PERIOD, AT LEAST ONE LIQUID-SEALING PARTITION DIVIDING THE INTERIOR OF THE BAG INTO A PLURALITYL OF TREATMENT COMPARTMENTS, A PASSAGE IN SAID PARTITION FOR SELECTIVE EXCHANGE OF STORED MATERIAL BETWEEN COMPARTMENTS, AND MEANS EXTERIORLY OF THE BAG FOR CLOSING SAID PASSAGE BY FORCING OPPOSITE SIDES OF THE BAG INTO SEALING ENGAGEMENT IN SAID PASSAGE, AND SAID BAG BEING CHARACTERIZED BY: (A) ITS ABILITY TO WITHSTAND CENTRIFUGAL FORCES OF CENTRIFUGING, (B) MAINTAINING STERILITY OF ITS CONTENTS, (C) PROVIDING PROPER HEAT TRANSFERE IN FREEZING AND THAWING OPERATIONS, (D) BEING COMPATIBLE WITH BLOOD AND LIQUID NITROGEN, AND (E) BEING FLEXIBLE AT ALL TEMPERATURES IN A RANGE FROM AMBIENT TO THE TEMPERATURE OF LIQUID NITROGEN.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US249942A US3257072A (en) | 1963-01-07 | 1963-01-07 | Whole blood storage structure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US249942A US3257072A (en) | 1963-01-07 | 1963-01-07 | Whole blood storage structure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3257072A true US3257072A (en) | 1966-06-21 |
Family
ID=22945664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US249942A Expired - Lifetime US3257072A (en) | 1963-01-07 | 1963-01-07 | Whole blood storage structure |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3257072A (en) |
Cited By (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3521454A (en) * | 1968-10-17 | 1970-07-21 | Foundation Sciences Inc | Bearing pad and method of preparing |
| US3660033A (en) * | 1969-09-29 | 1972-05-02 | Leroy L Schwartz | Disposable specimen collection and analysis bag |
| US3809224A (en) * | 1972-02-14 | 1974-05-07 | D Greenwood | Compartmented pouch |
| US3847279A (en) * | 1969-11-20 | 1974-11-12 | American Cyanamid Co | Package for plural reactable components with rupturable ultrasonic seal |
| US3911918A (en) * | 1972-04-13 | 1975-10-14 | Ralph D Turner | Blood collection, storage and administering bag |
| US4051804A (en) * | 1976-03-01 | 1977-10-04 | Garnett-Mckeen Chemical Corporation | Thaw-indicator device |
| FR2389383A1 (en) * | 1977-05-04 | 1978-12-01 | Johnson & Johnson | |
| WO1981003275A1 (en) * | 1980-05-12 | 1981-11-26 | Pennwalt Corp | Article for storage and transport of biogenic fluids |
| FR2497724A1 (en) * | 1981-01-09 | 1982-07-16 | Anatros Corp | METHOD AND APPARATUS FOR FORMING A PLASTIC ENCLOSURE FOR CONTAINING FLUIDS AND COMPRISING INTERIOR COMPARTMENTS CONNECTED THEREBY BETWEEN THEM |
| EP0069247A1 (en) * | 1981-07-03 | 1983-01-12 | Gambro Lundia AB | An apparatus for measuring the concentration of a low-molecular compound in a complex medium, especially whole blood |
| US4403992A (en) * | 1980-10-06 | 1983-09-13 | Sis-Ter S.P.A. | Continuous peritoneal dialysis bag device |
| WO1984002091A1 (en) * | 1982-11-26 | 1984-06-07 | Seroteknik Hb | Method and apparatus for centrifugal batch separation of blood |
| US4545481A (en) * | 1983-04-19 | 1985-10-08 | Marvin Elkins | Stencilling device |
| EP0167955A2 (en) * | 1984-07-13 | 1986-01-15 | Miles Inc. | Plasma bags |
| US4602910A (en) * | 1984-02-28 | 1986-07-29 | Larkin Mark E | Compartmented flexible solution container |
| US4731053A (en) * | 1986-12-23 | 1988-03-15 | Merck & Co., Inc. | Container device for separately storing and mixing two ingredients |
| WO1990010690A1 (en) * | 1989-03-10 | 1990-09-20 | Baxter International Inc. | Method and apparatus for in vitro reproduction and growth of cells in culture medium |
| US4994056A (en) * | 1989-11-09 | 1991-02-19 | Ikeda Daniel P | Unit dose medicament storing and mixing system |
| US5176634A (en) * | 1990-08-02 | 1993-01-05 | Mcgaw, Inc. | Flexible multiple compartment drug container |
| US5257985A (en) * | 1989-12-04 | 1993-11-02 | Richard Puhl | Multi-chamber intravenous bag apparatus |
| WO1993021892A1 (en) * | 1992-04-23 | 1993-11-11 | Seroteknik Hb | System and method for centrifugal separation of two or more fractions from a composite liquid, and a bag intended therefor |
| WO1994011086A1 (en) * | 1992-11-06 | 1994-05-26 | Baxter International Inc. | Method for filtering a body fluid using rinse chamber bag |
| US5394907A (en) * | 1990-07-19 | 1995-03-07 | Pharmacia Ab | Device and method for dosing a liquid product |
| EP0708674A1 (en) * | 1994-05-11 | 1996-05-01 | Baxter International Inc. | Blood collection system |
| WO1998007828A1 (en) * | 1996-08-16 | 1998-02-26 | Roche Diagnostics Gmbh | Device with a reaction bag for multi-step culturing/separation operations and/or reactions in several steps |
| US5910138A (en) * | 1996-05-13 | 1999-06-08 | B. Braun Medical, Inc. | Flexible medical container with selectively enlargeable compartments and method for making same |
| US5928213A (en) * | 1996-05-13 | 1999-07-27 | B. Braun Medical, Inc. | Flexible multiple compartment medical container with preferentially rupturable seals |
| US5944709A (en) * | 1996-05-13 | 1999-08-31 | B. Braun Medical, Inc. | Flexible, multiple-compartment drug container and method of making and using same |
| WO2000000242A3 (en) * | 1998-06-29 | 2000-02-24 | Orbon Corp | Drug dispenser |
| US6123696A (en) * | 1998-07-16 | 2000-09-26 | Thermogenesis Corp. | Centrifugation bag with yieldable partitions |
| US6186998B1 (en) * | 1997-12-09 | 2001-02-13 | Hosokawa Yoko Co., Ltd. | Bag for infusion solution and method of manufacturing same |
| US6491678B1 (en) * | 1994-12-05 | 2002-12-10 | New York Blood Center, Inc. | Freezer bag |
| US20030017066A1 (en) * | 2001-07-19 | 2003-01-23 | Baxter International Inc. | Apparatus, flexible bag and method for dispensing |
| US20040007588A1 (en) * | 2001-07-19 | 2004-01-15 | Baxter International Inc. | Flexible bag for use in manufacturing |
| US20040065679A1 (en) * | 2000-11-13 | 2004-04-08 | Marc Peuker | Device for storing and dispensing flowable compositions |
| US20040078023A1 (en) * | 2002-10-17 | 2004-04-22 | Paul-Andre Gollier | Peelable seal |
| US20040144800A1 (en) * | 2003-01-24 | 2004-07-29 | Baxter International, Inc. | Liquid dispenser and flexible bag therefor |
| US20040144799A1 (en) * | 2003-01-24 | 2004-07-29 | Baxter International Inc. | Liquid dispenser and flexible bag therefor |
| US20050011908A1 (en) * | 2003-07-16 | 2005-01-20 | Baxter International, Inc. | Dispenser and pressure/vacuum converting machine |
| US6905314B2 (en) | 2001-10-16 | 2005-06-14 | Baxter International Inc. | Pump having flexible liner and compounding apparatus having such a pump |
| US20050194060A1 (en) * | 2004-03-03 | 2005-09-08 | Vincent Houwaert | Peelable seal closure assembly |
| US20060084178A1 (en) * | 2004-10-15 | 2006-04-20 | Peyton Barbara M | Trace ammonia colorimetric test apparatus |
| US20060132247A1 (en) * | 2004-12-20 | 2006-06-22 | Renesas Technology Corp. | Oscillator and charge pump circuit using the same |
| US7169547B2 (en) | 1994-12-05 | 2007-01-30 | New York Blood Center, Inc. | High concentration white blood cells as a therapeutic product |
| US20070251838A1 (en) * | 2003-12-02 | 2007-11-01 | Fuso Pharmaceutical Industries, Ltd | Multi-Chamber Container |
| US20080004594A1 (en) * | 2004-07-29 | 2008-01-03 | Olof Pahlberg | Flexible Multi-Chamber Container for the Preparation of Medical Mixed Solutions |
| US20080017543A1 (en) * | 2004-07-29 | 2008-01-24 | Olof Pahlberg | Medical Container With Improved Peelable Seal |
| US7678097B1 (en) | 1999-11-12 | 2010-03-16 | Baxter International Inc. | Containers and methods for manufacturing same |
| US20100120596A1 (en) * | 2007-05-23 | 2010-05-13 | Ge Healthcare Bio-Sciences Ab | Separation device |
| US20100281886A1 (en) * | 2006-09-11 | 2010-11-11 | Core Dynamics Limited | Systems, devices and methods for freezing and thawing biological materials |
| US20110022022A1 (en) * | 2007-07-19 | 2011-01-27 | Tatsuro Tsuruoka | Multi-chamber bag |
| WO2012027847A1 (en) * | 2010-08-31 | 2012-03-08 | Canadian Blood Services | Container for non-invasive fluid sample access |
| US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
| US20150140656A1 (en) * | 2013-11-20 | 2015-05-21 | Cellulis, S.L. | Method of freezing cells |
| US20150216763A1 (en) * | 2014-02-05 | 2015-08-06 | Muffin Incorporated | Compartmented cryopreservation container and uses thereof |
| WO2015180908A1 (en) * | 2014-05-28 | 2015-12-03 | Ge Healthcare Bio-Sciences Ab | Bag assembly for cultivation of cells |
| EP3127998A3 (en) * | 2015-08-04 | 2017-04-19 | Olympus Corporation | Cell culture apparatus and method of culturing cells |
| DE102018128010A1 (en) * | 2018-11-08 | 2020-05-14 | Bastian Steudel | Bioreactor for the cultivation of photoautotrophic microorganisms and their use |
| US10731118B2 (en) | 2014-05-28 | 2020-08-04 | Ge Healthcare Bio-Sciences Corp. | Bag assembly for cultivation of cells |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2437518A (en) * | 1943-07-17 | 1948-03-09 | Pharmacia Ab | Manufacture of infusion and injection fluids |
| US2695614A (en) * | 1952-12-10 | 1954-11-30 | Compule Corp | Plural-compartment admixing vial |
| US2753990A (en) * | 1953-07-02 | 1956-07-10 | Chalfin Philip | Container |
| US2808829A (en) * | 1955-04-06 | 1957-10-08 | Cutter Lab | Blood transfusion equipment |
| US2833691A (en) * | 1951-07-24 | 1958-05-06 | Rohm & Haas | Blood preservation by ion exchange resin decalcification |
| US2838046A (en) * | 1955-04-06 | 1958-06-10 | Cutter Lab | Container for blood and the like |
| US2893547A (en) * | 1957-05-01 | 1959-07-07 | Fenwal Inc | Kit and packaging, mixing and dispensing means for mixture ingredients |
| US3064802A (en) * | 1960-07-25 | 1962-11-20 | Fenwal Inc | Kit and packaging, mixing and dispensing means for mixture ingredients |
| US3064647A (en) * | 1957-06-13 | 1962-11-20 | Baxter Laboratories Inc | Blood component separation method and apparatus |
| US3082867A (en) * | 1961-04-10 | 1963-03-26 | Traffic Control Inc | Compartmented package and divider therefor |
-
1963
- 1963-01-07 US US249942A patent/US3257072A/en not_active Expired - Lifetime
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2437518A (en) * | 1943-07-17 | 1948-03-09 | Pharmacia Ab | Manufacture of infusion and injection fluids |
| US2833691A (en) * | 1951-07-24 | 1958-05-06 | Rohm & Haas | Blood preservation by ion exchange resin decalcification |
| US2695614A (en) * | 1952-12-10 | 1954-11-30 | Compule Corp | Plural-compartment admixing vial |
| US2753990A (en) * | 1953-07-02 | 1956-07-10 | Chalfin Philip | Container |
| US2808829A (en) * | 1955-04-06 | 1957-10-08 | Cutter Lab | Blood transfusion equipment |
| US2838046A (en) * | 1955-04-06 | 1958-06-10 | Cutter Lab | Container for blood and the like |
| US2893547A (en) * | 1957-05-01 | 1959-07-07 | Fenwal Inc | Kit and packaging, mixing and dispensing means for mixture ingredients |
| US3064647A (en) * | 1957-06-13 | 1962-11-20 | Baxter Laboratories Inc | Blood component separation method and apparatus |
| US3064802A (en) * | 1960-07-25 | 1962-11-20 | Fenwal Inc | Kit and packaging, mixing and dispensing means for mixture ingredients |
| US3082867A (en) * | 1961-04-10 | 1963-03-26 | Traffic Control Inc | Compartmented package and divider therefor |
Cited By (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3521454A (en) * | 1968-10-17 | 1970-07-21 | Foundation Sciences Inc | Bearing pad and method of preparing |
| US3660033A (en) * | 1969-09-29 | 1972-05-02 | Leroy L Schwartz | Disposable specimen collection and analysis bag |
| US3847279A (en) * | 1969-11-20 | 1974-11-12 | American Cyanamid Co | Package for plural reactable components with rupturable ultrasonic seal |
| US3809224A (en) * | 1972-02-14 | 1974-05-07 | D Greenwood | Compartmented pouch |
| US3911918A (en) * | 1972-04-13 | 1975-10-14 | Ralph D Turner | Blood collection, storage and administering bag |
| US4051804A (en) * | 1976-03-01 | 1977-10-04 | Garnett-Mckeen Chemical Corporation | Thaw-indicator device |
| FR2389383A1 (en) * | 1977-05-04 | 1978-12-01 | Johnson & Johnson | |
| US4235233A (en) * | 1977-05-04 | 1980-11-25 | Johnson & Johnson | Bag for collecting, storing and administering including filtering blood, blood components, intravenous fluids and similar fluids |
| US4346710A (en) * | 1978-06-16 | 1982-08-31 | Pennwalt Corporation | Article for storage and transport of biogenic fluids |
| WO1981003275A1 (en) * | 1980-05-12 | 1981-11-26 | Pennwalt Corp | Article for storage and transport of biogenic fluids |
| US4403992A (en) * | 1980-10-06 | 1983-09-13 | Sis-Ter S.P.A. | Continuous peritoneal dialysis bag device |
| FR2497724A1 (en) * | 1981-01-09 | 1982-07-16 | Anatros Corp | METHOD AND APPARATUS FOR FORMING A PLASTIC ENCLOSURE FOR CONTAINING FLUIDS AND COMPRISING INTERIOR COMPARTMENTS CONNECTED THEREBY BETWEEN THEM |
| US4548023A (en) * | 1981-01-09 | 1985-10-22 | Anatros Corporation | Method and apparatus for forming a plastic enclosure for fluids with selectively interconnectable internal compartments |
| EP0069247A1 (en) * | 1981-07-03 | 1983-01-12 | Gambro Lundia AB | An apparatus for measuring the concentration of a low-molecular compound in a complex medium, especially whole blood |
| WO1984002091A1 (en) * | 1982-11-26 | 1984-06-07 | Seroteknik Hb | Method and apparatus for centrifugal batch separation of blood |
| US4617009A (en) * | 1982-11-26 | 1986-10-14 | Seroteknik Hg | Method and apparatus for centrifugal batch separation of blood |
| US4545481A (en) * | 1983-04-19 | 1985-10-08 | Marvin Elkins | Stencilling device |
| US4602910A (en) * | 1984-02-28 | 1986-07-29 | Larkin Mark E | Compartmented flexible solution container |
| EP0167955A2 (en) * | 1984-07-13 | 1986-01-15 | Miles Inc. | Plasma bags |
| EP0167955A3 (en) * | 1984-07-13 | 1987-06-16 | Miles Laboratories, Inc. | Plasma bags |
| US4731053A (en) * | 1986-12-23 | 1988-03-15 | Merck & Co., Inc. | Container device for separately storing and mixing two ingredients |
| EP0272864A2 (en) * | 1986-12-23 | 1988-06-29 | Merck & Co. Inc. | Container device for separately storing and mixing two ingredients |
| EP0272864A3 (en) * | 1986-12-23 | 1988-09-07 | Merck & Co. Inc. | Container device for separately storing and mixing two ingredients |
| WO1990010690A1 (en) * | 1989-03-10 | 1990-09-20 | Baxter International Inc. | Method and apparatus for in vitro reproduction and growth of cells in culture medium |
| US5017490A (en) * | 1989-03-10 | 1991-05-21 | Baxter International Inc. | Method for in vitro reproduction and growth of cells in culture medium |
| US4994056A (en) * | 1989-11-09 | 1991-02-19 | Ikeda Daniel P | Unit dose medicament storing and mixing system |
| US5257985A (en) * | 1989-12-04 | 1993-11-02 | Richard Puhl | Multi-chamber intravenous bag apparatus |
| US5394907A (en) * | 1990-07-19 | 1995-03-07 | Pharmacia Ab | Device and method for dosing a liquid product |
| US5176634A (en) * | 1990-08-02 | 1993-01-05 | Mcgaw, Inc. | Flexible multiple compartment drug container |
| WO1993021892A1 (en) * | 1992-04-23 | 1993-11-11 | Seroteknik Hb | System and method for centrifugal separation of two or more fractions from a composite liquid, and a bag intended therefor |
| WO1994011086A1 (en) * | 1992-11-06 | 1994-05-26 | Baxter International Inc. | Method for filtering a body fluid using rinse chamber bag |
| AU665140B2 (en) * | 1992-11-06 | 1995-12-14 | Baxter International Inc. | Method for filtering a body fluid using rinse chamber bag |
| US5316681A (en) * | 1992-11-06 | 1994-05-31 | Baxter International Inc. | Method of filtering body fluid using a rinse chamber bag |
| EP0708674A4 (en) * | 1994-05-11 | 1998-10-28 | Baxter Int | Blood collection system |
| EP0708674A1 (en) * | 1994-05-11 | 1996-05-01 | Baxter International Inc. | Blood collection system |
| US7169547B2 (en) | 1994-12-05 | 2007-01-30 | New York Blood Center, Inc. | High concentration white blood cells as a therapeutic product |
| US6491678B1 (en) * | 1994-12-05 | 2002-12-10 | New York Blood Center, Inc. | Freezer bag |
| US20070179424A1 (en) * | 1994-12-05 | 2007-08-02 | Pablo Rubinstein | High concentration white cells, a method for agglomeration of the high concentration and a bag set for use in conjunction therewith |
| US6468377B1 (en) | 1996-05-13 | 2002-10-22 | B. Braun Medical Inc. | Flexible medical container with selectively enlargeable compartments and method for making same |
| US6996951B2 (en) | 1996-05-13 | 2006-02-14 | B. Braun Medical Inc. | Flexible multi-compartment container with peelable seals and method for making same |
| US20040068960A1 (en) * | 1996-05-13 | 2004-04-15 | Smith Steven L. | Flexible multi-compartment container with peelable seals and method for making same |
| US6165161A (en) * | 1996-05-13 | 2000-12-26 | B. Braun Medical, Inc. | Sacrificial port for filling flexible, multiple-compartment drug container |
| US6198106B1 (en) | 1996-05-13 | 2001-03-06 | B. Braun Medical, Inc. | Transport and sterilization carrier for flexible, multiple compartment drug container |
| US6203535B1 (en) | 1996-05-13 | 2001-03-20 | B. Braun Medical, Inc. | Method of making and using a flexible, multiple-compartment drug container |
| US5910138A (en) * | 1996-05-13 | 1999-06-08 | B. Braun Medical, Inc. | Flexible medical container with selectively enlargeable compartments and method for making same |
| US5944709A (en) * | 1996-05-13 | 1999-08-31 | B. Braun Medical, Inc. | Flexible, multiple-compartment drug container and method of making and using same |
| US20030000632A1 (en) * | 1996-05-13 | 2003-01-02 | Sperko William A. | Flexible medical container with selectively enlargeable compartments and method for making same |
| US6764567B2 (en) | 1996-05-13 | 2004-07-20 | B. Braun Medical | Flexible medical container with selectively enlargeable compartments and method for making same |
| US5928213A (en) * | 1996-05-13 | 1999-07-27 | B. Braun Medical, Inc. | Flexible multiple compartment medical container with preferentially rupturable seals |
| US6846305B2 (en) | 1996-05-13 | 2005-01-25 | B. Braun Medical Inc. | Flexible multi-compartment container with peelable seals and method for making same |
| WO1998007828A1 (en) * | 1996-08-16 | 1998-02-26 | Roche Diagnostics Gmbh | Device with a reaction bag for multi-step culturing/separation operations and/or reactions in several steps |
| US6186998B1 (en) * | 1997-12-09 | 2001-02-13 | Hosokawa Yoko Co., Ltd. | Bag for infusion solution and method of manufacturing same |
| WO2000000242A3 (en) * | 1998-06-29 | 2000-02-24 | Orbon Corp | Drug dispenser |
| US6123696A (en) * | 1998-07-16 | 2000-09-26 | Thermogenesis Corp. | Centrifugation bag with yieldable partitions |
| US7678097B1 (en) | 1999-11-12 | 2010-03-16 | Baxter International Inc. | Containers and methods for manufacturing same |
| US20070144923A1 (en) * | 1999-11-12 | 2007-06-28 | Vincent Houwaert | Peelable seal closure assembly |
| US7770611B2 (en) | 1999-11-12 | 2010-08-10 | Baxter International Inc. | Peelable seal closure assembly |
| US20040065679A1 (en) * | 2000-11-13 | 2004-04-08 | Marc Peuker | Device for storing and dispensing flowable compositions |
| US7097075B2 (en) * | 2000-11-13 | 2006-08-29 | 3M Espe Ag | Device for storing and dispensing flowable compositions |
| US6769231B2 (en) | 2001-07-19 | 2004-08-03 | Baxter International, Inc. | Apparatus, method and flexible bag for use in manufacturing |
| US20030017066A1 (en) * | 2001-07-19 | 2003-01-23 | Baxter International Inc. | Apparatus, flexible bag and method for dispensing |
| US20040007588A1 (en) * | 2001-07-19 | 2004-01-15 | Baxter International Inc. | Flexible bag for use in manufacturing |
| US20040094573A1 (en) * | 2001-07-19 | 2004-05-20 | Baxter International Inc. | Flow control apparatus for use in dispensing fluent material |
| US6905314B2 (en) | 2001-10-16 | 2005-06-14 | Baxter International Inc. | Pump having flexible liner and compounding apparatus having such a pump |
| US7546918B2 (en) | 2002-10-17 | 2009-06-16 | Baxter International Inc. | Peelable seal |
| US7175614B2 (en) | 2002-10-17 | 2007-02-13 | Baxter International Inc. | Peelable seal |
| US20040078023A1 (en) * | 2002-10-17 | 2004-04-22 | Paul-Andre Gollier | Peelable seal |
| US20070088314A1 (en) * | 2002-10-17 | 2007-04-19 | Paul-Andre Gollier | Peelable seal |
| US20040144799A1 (en) * | 2003-01-24 | 2004-07-29 | Baxter International Inc. | Liquid dispenser and flexible bag therefor |
| US7007824B2 (en) | 2003-01-24 | 2006-03-07 | Baxter International Inc. | Liquid dispenser and flexible bag therefor |
| US7237691B2 (en) | 2003-01-24 | 2007-07-03 | Baxter International Inc. | Flexible bag for fluent material dispenser |
| US20040144800A1 (en) * | 2003-01-24 | 2004-07-29 | Baxter International, Inc. | Liquid dispenser and flexible bag therefor |
| US20050011908A1 (en) * | 2003-07-16 | 2005-01-20 | Baxter International, Inc. | Dispenser and pressure/vacuum converting machine |
| US20070251838A1 (en) * | 2003-12-02 | 2007-11-01 | Fuso Pharmaceutical Industries, Ltd | Multi-Chamber Container |
| US8336705B2 (en) * | 2003-12-02 | 2012-12-25 | Fuso Pharmaceuticals Industries, Ltd. | Multi-chamber container |
| US20050194060A1 (en) * | 2004-03-03 | 2005-09-08 | Vincent Houwaert | Peelable seal closure assembly |
| US20080004594A1 (en) * | 2004-07-29 | 2008-01-03 | Olof Pahlberg | Flexible Multi-Chamber Container for the Preparation of Medical Mixed Solutions |
| US20080017543A1 (en) * | 2004-07-29 | 2008-01-24 | Olof Pahlberg | Medical Container With Improved Peelable Seal |
| US7875016B2 (en) * | 2004-07-29 | 2011-01-25 | Fresenius Kabi Deutschland Gmbh | Flexible multi-chamber container for the preparation of medical mixed solutions |
| US7875015B2 (en) | 2004-07-29 | 2011-01-25 | Fresenius Kabi Deutschland Gmbh | Medical container with improved peelable seal |
| US20060084178A1 (en) * | 2004-10-15 | 2006-04-20 | Peyton Barbara M | Trace ammonia colorimetric test apparatus |
| US20060132247A1 (en) * | 2004-12-20 | 2006-06-22 | Renesas Technology Corp. | Oscillator and charge pump circuit using the same |
| US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
| US20100281886A1 (en) * | 2006-09-11 | 2010-11-11 | Core Dynamics Limited | Systems, devices and methods for freezing and thawing biological materials |
| US20100120596A1 (en) * | 2007-05-23 | 2010-05-13 | Ge Healthcare Bio-Sciences Ab | Separation device |
| US20110022022A1 (en) * | 2007-07-19 | 2011-01-27 | Tatsuro Tsuruoka | Multi-chamber bag |
| US8845611B2 (en) * | 2007-07-19 | 2014-09-30 | Otsuka Pharmaceutical Factory, Inc. | Multi-chamber bag |
| WO2012027847A1 (en) * | 2010-08-31 | 2012-03-08 | Canadian Blood Services | Container for non-invasive fluid sample access |
| US9615570B2 (en) * | 2013-11-20 | 2017-04-11 | Cellulis, S.L. | Method of freezing cells |
| US20150140656A1 (en) * | 2013-11-20 | 2015-05-21 | Cellulis, S.L. | Method of freezing cells |
| US10077423B2 (en) * | 2014-02-05 | 2018-09-18 | Muffin Incorporated | Compartmented cryopreservation container and uses thereof |
| JP2017506097A (en) * | 2014-02-05 | 2017-03-02 | マフィン・インコーポレイテッドＭｕｆｆｉｎ Ｉｎｃｏｒｐｏｒａｔｅｄ | Compartmented cryopreservation container and use thereof |
| EP3102031A4 (en) * | 2014-02-05 | 2018-02-21 | Muffin Incorporated | Compartmented cryopreservation container and uses thereof |
| US20150216763A1 (en) * | 2014-02-05 | 2015-08-06 | Muffin Incorporated | Compartmented cryopreservation container and uses thereof |
| US11261423B2 (en) | 2014-02-05 | 2022-03-01 | Muffin Incorporated | Compartmented cryopreservation container and uses thereof |
| WO2015180908A1 (en) * | 2014-05-28 | 2015-12-03 | Ge Healthcare Bio-Sciences Ab | Bag assembly for cultivation of cells |
| US10450540B2 (en) | 2014-05-28 | 2019-10-22 | Ge Healthcare Bio-Sciences Ab | Bag assembly for cultivation of cells |
| US10731118B2 (en) | 2014-05-28 | 2020-08-04 | Ge Healthcare Bio-Sciences Corp. | Bag assembly for cultivation of cells |
| US11525111B2 (en) | 2014-05-28 | 2022-12-13 | Cytiva Sweden Ab | Bag assembly for cultivation of cells |
| EP3127998A3 (en) * | 2015-08-04 | 2017-04-19 | Olympus Corporation | Cell culture apparatus and method of culturing cells |
| US10308906B2 (en) | 2015-08-04 | 2019-06-04 | Olympus Corporation | Cell culture apparatus and method of culturing cells |
| DE102018128010A1 (en) * | 2018-11-08 | 2020-05-14 | Bastian Steudel | Bioreactor for the cultivation of photoautotrophic microorganisms and their use |
| DE102018128010B4 (en) * | 2018-11-08 | 2021-02-11 | Bastian Steudel | Bioreactor for cultivating photoautotrophic microorganisms and its use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3257072A (en) | Whole blood storage structure | |
| US20230363374A1 (en) | Packaging assembly for storing tissue and cellular material | |
| AU621553B2 (en) | Improved system | |
| USRE27359E (en) | Method and apparatus for treating blood | |
| CA1336380C (en) | Apparatus and method for collecting and freezing blood plasma | |
| US3064647A (en) | Blood component separation method and apparatus | |
| US4610684A (en) | Flexible container and mixing system for storing and preparing I.V. fluids | |
| US7618584B2 (en) | Bag system for the cryopreservation of body fluids | |
| EP0796040B1 (en) | Method and bag set for concentrating white cells | |
| US4040959A (en) | Multi-purpose blood bag | |
| US2950716A (en) | Fluid handling method and apparatus | |
| US7727219B2 (en) | Sterile system and methods for collecting, transporting, storing and cyropreserving body fluids | |
| Simon et al. | Extension of platelet concentrate storage to 7 days in second‐generation bags | |
| WO2006078796A2 (en) | Apparatus and method for stem cell preservation and usage | |
| EP0505962A1 (en) | Method and pre-assembled kit for obtaining fibrogen in a full sterile environment | |
| TW477696B (en) | A bag system for collecting and storing blood and a method therefor | |
| Abbruzzese et al. | A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experience | |
| RU2749633C1 (en) | System for lyophilization, storage and use of biological material | |
| JPH09276367A (en) | Cryogenic storage bag | |
| US20130144247A1 (en) | Biologic storage bag modifications facilitating sample extraction and unit subdivision | |
| Molina et al. | Comparison of rigid polymer vials and flexible bags for the cryopreservation of t cells | |
| US10729366B2 (en) | Spherical biomedical sampling and mixing container | |
| IE903834A1 (en) | Apparatus and method for collecting and freezing blood¹plasma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: FIRST NATIONAL BANK OF BOSTON, AS AGENT Free format text: CONDITIONAL ASSIGNMENT;ASSIGNOR:HELIX TECHNOLOGY CORPORATION;REEL/FRAME:003885/0445 Effective date: 19810219 |
|
| AS | Assignment |
Owner name: CHEMICAL BANK Free format text: SECURITY INTEREST;ASSIGNOR:CYENCO, INC.;REEL/FRAME:005824/0817 Effective date: 19910830 |